InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-36.1%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by TOMSICEK MICHAEL JOHN. Officer active across 2 companies, notably CRISPR Therapeutics AG. Aggregated, 3 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €82k. Activity tracked since 6 August 2021. The latest transaction was filed on 19 October 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations3 total
15,000 shares@ US$5.32100.0% of flowCommon SharesSEC:0001209191-22-054325:0
Canonical exit: 17 Jan 2023 (T+90)
25,000 shares@ US$17.750.0080% mcap50.0% of flowCommon SharesSEC:0001209191-21-050719:0
25,000 shares@ US$17.7550.0% of flowCommon SharesSEC:0001209191-21-050719
3 of 3 declarations
